KAYO MOTOR
834058
Zhejiang Zoenn Design
300901
Zhejiang Meorient Commerce & Exhibition Inc.
300795
Fujian Zitian Media Technology
300280
Zhejiang Prulde Electric Appliance
301353
CN Stock MarketDetailed Quotes
688575 Shenzhen YHLO Biotech
- 17.40
- -0.37-2.08%
Market Closed Dec 13 15:00 CST
9.92BMarket Cap34.39P/E (TTM)
17.74High17.32Low76.80KlotVolume17.69Open17.77Pre Close134.19MTurnover1.35%Turnover Ratio27.93P/E (Static)570.27MShares28.2752wk High3.73P/B9.92BFloat Cap16.8252wk Low21.32Limit Up570.27MShs Float51.71Historical High14.22Limit Down2.36%Amplitude15.04Historical Low0.27Dividend TTM17.47Avg Price43.19KlotAsk1.57%Div YieldTTM100Lot Size29.31KlotBid
Shenzhen YHLO Biotech Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -9.78%1.39B | -10.69%960.03M | -34.65%431.32M | -48.42%2.05B | -50.63%1.54B | -54.00%1.07B | -51.82%660M | 237.95%3.98B | 265.06%3.13B | 326.46%2.34B |
| Operating revenue | -9.78%1.39B | -10.69%960.03M | -34.65%431.32M | -48.42%2.05B | -50.63%1.54B | -54.00%1.07B | -51.82%660M | 237.95%3.98B | 265.06%3.13B | 326.46%2.34B |
| Total operating cost | -12.26%1.18B | -15.00%795.97M | -33.89%375.49M | -34.72%1.78B | -36.54%1.34B | -41.22%936.48M | -26.11%567.94M | 183.47%2.72B | 206.38%2.11B | 255.02%1.59B |
| Operating cost | -29.74%506.16M | -33.48%362.31M | -55.80%162.43M | -51.61%886.81M | -47.25%720.43M | -46.81%544.66M | -24.77%367.49M | 260.50%1.83B | 267.54%1.37B | 318.08%1.02B |
| Operating tax surcharges | -9.71%8.75M | -17.38%6.5M | -73.16%1.66M | -57.62%13.44M | -65.38%9.69M | -63.41%7.87M | 14.40%6.17M | 238.05%31.72M | 311.82%28M | 379.70%21.51M |
| Operating expense | 6.47%299.67M | 10.70%191.87M | 8.63%91.43M | -19.81%395.37M | -35.69%281.45M | -50.57%173.33M | -51.96%84.17M | 128.09%493.03M | 204.17%437.64M | 290.54%350.63M |
| Administration expense | 0.37%125.8M | -4.50%81.1M | -31.22%36.29M | 31.55%172.25M | 4.05%125.33M | 4.16%84.92M | 23.19%52.76M | 53.67%130.94M | 100.00%120.46M | 117.43%81.53M |
| Financial expense | 158.65%6.27M | 99.25%-87.89K | 94.84%-118.07K | -6.71%-9.86M | 37.57%-10.69M | 12.26%-11.73M | -216.90%-2.29M | -197.54%-9.24M | -327.98%-17.13M | -295.71%-13.37M |
| -Interest expense (Financial expense) | 156.03%8.36M | 29.32%2.69M | 18.80%1.15M | -25.61%6.25M | -51.85%3.26M | -47.93%2.08M | -41.26%967.96K | -25.08%8.41M | -24.66%6.78M | -42.40%4M |
| -Interest Income (Financial expense) | 67.53%-4.1M | 69.57%-3.1M | 67.67%-2.08M | -58.77%-14.31M | -152.76%-12.64M | -255.96%-10.18M | -556.13%-6.43M | -67.98%-9.01M | -50.41%-5M | -74.33%-2.86M |
| Research and development | 7.13%229.49M | 12.26%154.27M | 40.52%83.8M | 31.99%317.18M | 20.56%214.21M | 6.60%137.43M | 8.83%59.64M | 83.81%240.31M | 78.68%177.68M | 97.57%128.92M |
| Credit Impairment Loss | -7.25%-3.96M | -570.85%-4.6M | -873.16%-5.86M | 34.84%-7.84M | 76.05%-3.69M | 81.53%-685.97K | 44.16%-602.25K | -318.31%-12.03M | -568.77%-15.42M | -159.57%-3.71M |
| Asset Impairment Loss | 122.25%7.79M | 208.03%9.25M | 215.57%7.28M | 43.93%-72.87M | 15.95%-35.02M | 80.96%-8.56M | 44.48%-6.3M | -716.00%-129.97M | -472.78%-41.66M | -646.89%-44.97M |
| Other net revenue | ||||||||||
| Fair value change income | 43.58%-14.95M | 17.71%-8.52M | 64.36%-5.51M | -146.27%-25.78M | -156.71%-26.5M | -117.53%-10.35M | -3,750.33%-15.46M | 37,942.90%55.71M | 19,361.48%46.73M | 1,083,425.66%59.04M |
| Invest income | -113.03%-15.02M | -372.85%-9.89M | -422.89%-5.55M | 2,092.04%118.08M | 2,230.17%115.27M | 124.00%3.62M | 1,186.33%1.72M | 81.51%5.39M | 164.22%4.95M | 630.64%1.62M |
| -Including: Investment income associates | -1,285.78%-23.22M | -1,286.14%-14.78M | -1,125.20%-8.12M | -383.33%-15.46M | -68.84%-1.68M | -22.53%-1.07M | -9.43%-662.48K | -734.77%-3.2M | ---992.42K | ---870.4K |
| Asset deal income | -102.70%-456.49K | 693.91%1.8M | ---830.35 | --2.79M | ---225.2K | ---302.83K | ---- | ---- | ---- | ---- |
| Other revenue | -6.91%27.07M | -7.74%22.64M | 36.04%17.81M | 128.08%48.26M | 61.46%29.08M | 147.75%24.54M | 414.96%13.09M | -11.56%21.16M | 22.72%18.01M | 20.79%9.9M |
| Operating profit | -23.01%218.2M | 19.08%174.74M | -24.26%64M | -71.66%340.55M | -72.46%283.43M | -80.83%146.75M | -85.72%84.51M | 429.77%1.2B | 488.46%1.03B | 664.27%765.63M |
| Add:Non operating Income | 9.50%4.25M | -78.81%404.96K | 825.71%34.89K | 795.88%7.14M | 564.66%3.88M | 344.72%1.91M | -90.51%3.77K | -72.49%796.7K | -26.21%584.3K | 140.00%429.64K |
| Less:Non operating expense | -75.69%2.25M | -57.70%1.38M | -52.69%543.33K | -15.32%13.57M | 6.07%9.27M | -31.04%3.26M | 0.37%1.15M | 711.00%16.03M | 1,049.83%8.74M | 1,623.87%4.72M |
| Total profit | -20.80%220.2M | 19.51%173.77M | -23.83%63.5M | -71.84%334.11M | -72.77%278.05M | -80.90%145.41M | -85.89%83.36M | 420.95%1.19B | 483.69%1.02B | 660.71%761.34M |
| Less:Income tax cost | -23.61%27.39M | -42.66%18.34M | -51.62%7.56M | -66.77%54.91M | -71.43%35.85M | -69.50%31.99M | -81.11%15.62M | 591.01%165.22M | 582.83%125.48M | 1,097.12%104.89M |
| Net profit | -20.39%192.82M | 37.05%155.43M | -17.42%55.94M | -72.66%279.2M | -72.96%242.19M | -82.72%113.41M | -86.67%67.74M | 401.00%1.02B | 472.05%895.7M | 618.84%656.45M |
| Net profit from continuing operation | -20.39%192.82M | 37.05%155.43M | -17.42%55.94M | -72.66%279.2M | -72.96%242.19M | -82.72%113.41M | -86.67%67.74M | 401.00%1.02B | 472.05%895.7M | 618.84%656.45M |
| Less:Minority Profit | 39.70%-25.82M | 37.41%-17.6M | 25.19%-10.09M | -928.27%-75.81M | -290.51%-42.82M | -203.24%-28.12M | -315.18%-13.49M | 1,115.86%9.15M | 1,281.52%22.48M | -436.13%-9.27M |
| Net profit of parent company owners | -23.29%218.64M | 22.25%173.03M | -18.72%66.03M | -64.92%355.01M | -67.36%285.02M | -78.74%141.53M | -84.11%81.24M | 394.33%1.01B | 463.55%873.22M | 651.70%665.72M |
| Earning per share | ||||||||||
| Basic earning per share | -24.00%0.38 | 20.00%0.3 | -14.29%0.12 | -64.80%0.63 | -67.53%0.5 | -78.63%0.25 | -84.44%0.14 | 371.05%1.79 | 431.03%1.54 | 588.24%1.17 |
| Diluted earning per share | -24.00%0.38 | 20.00%0.3 | -14.29%0.12 | -65.17%0.62 | -67.53%0.5 | -78.63%0.25 | -84.44%0.14 | 368.42%1.78 | 275.61%1.54 | 387.50%1.17 |
| Other composite income | -846.34%-2.51M | -279.15%-4.41M | 408.22%4.97M | -102.25%-314.6K | -96.83%336.62K | 152.78%2.46M | -240.54%-1.61M | 3,584.66%13.96M | 13,446.55%10.6M | -15,375.84%-4.67M |
| Other composite income of parent company owners | -846.34%-2.51M | -279.15%-4.41M | 408.22%4.97M | -102.25%-314.6K | -96.83%336.62K | 152.78%2.46M | -240.54%-1.61M | 3,584.66%13.96M | 13,446.55%10.6M | -15,375.84%-4.67M |
| Total composite income | -21.53%190.3M | 30.33%151.02M | -7.90%60.91M | -73.06%278.89M | -73.24%242.53M | -82.22%115.87M | -86.97%66.13M | 406.91%1.04B | 479.12%906.3M | 613.96%651.78M |
| Total composite income of parent company owners | -24.26%216.13M | 17.10%168.62M | -10.83%71M | -65.43%354.7M | -67.71%285.35M | -78.22%144M | -84.42%79.63M | 400.22%1.03B | 470.69%883.82M | 646.69%661.06M |
| Total composite income of minority owners | 39.70%-25.82M | 37.41%-17.6M | 25.19%-10.09M | -928.27%-75.81M | -290.51%-42.82M | -203.24%-28.12M | -315.18%-13.49M | 1,115.86%9.15M | 1,281.52%22.48M | -436.13%-9.27M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership) | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
